Abstract-In eight young healthy subjects on a 240 mM Na diet mean arterial pressure (MAP), renal hemodynamlcs and renal handling of Na and exogenous Ll were measured at baseline and durmg acute nitric oxide (NO) mhlbltlon with 90-minute mfuslon of 3 Opg/kg mm-' of NC-L-argmme methyl ester (L-NAME) The same experiment was repeated with mfuslon of 50pg/kg mm-' of DA, receptor blocker L-Sulpmde (L-SULP) alone and, finally, with simultaneous mfuslon of both L-NAME and L-SULP L-SULP alone did not elicit any effect L-NAME alone produced no changes m MAP from 0 to 45 minutes (PJ and a 6 6% increase at 45 to 90 minutes (P2) of mfuslon Effective renal plasma flow (ERPF, PAH clearance) and glomerular filtration rate (GFR, muhn clearance) declined by 10 2% and 7 6%, respectively, m P, and by 15 3% and 11 5% m P, Flltratlon Fraction (FF) rose by 4 2% m Pz Calculated renal vascular resistance (RVR) increased by 13 0% to 25.6% Fractional excretion of Na (FENa) and L1 (FEL1) fell by 20 0% and by 16.0%, respectively, m P, and by 40 0% and 25 1% m Pz All these vanatlons, except for MAP and GFR, were slgmficantly greater during comfuslon of L-NAME and L-SULP ERPF declined by 17 8% to 33 7%, FENa by 26 7% to 53 3%, FELl by 13 8% to 34 8%, while RVR rose by 22 5% to 59 1% and FF by 10 1% to 29 3% The present data confirm that NO blockade with low-dose systemic mfuslon of L-NAME produces renal vasoconstnctlon, reduced GFR with slight increase m FF, and enhanced tubular Ll, and Na reabsorption Since increase m RVR and FF and decrease m FENa and FELl are markedly potentlated by the simultaneous mfuslon of DA2 blocker L-SULP, which exerts no effects by Itself, we suggest that DA mteractlons between DA system at the level of DA2 receptors and basal NO production play a physlologlcal role m the regulation of renal function m humans (Hypertension, 1998;31[part2]:277-282.)
T he endogenous cathecolamme dopamme (DA) 1s involved m a wide variety of physlologlcal processes and contributes to modulation of many functions including behavior, movement, nerve conduction, hormone synthesis and release, blood pressure and renal hemodynamlcs, and sodium handling Outside of the central nervous system, DA receptors have been divided on the basis of their locahsatlon into two maJor groups, the presynaptlc (DA,) and postsynaptlc (DA,) subtypes 1~23 Wlthm the kidney, DA, receptors have been localized postsynaptlcally m blood vessels, proximal convoluted tubule, and collectmg duct 133 Increase m ademlcyclase actlvlty, renal vasodllatlon and natnurens, mhlbltable by DA, antagorusts, are known to follow DA, receptor stlmulatlon by infusion of DA or specific DA, agomstlc drugs 1~ DA, receptors have been identified presynaptlcally on sympathetic nerve termmals m the adventltla of the renal vasculature I,* 7 Due to their preJunctlona1 locahsatlon, DA2 receptor actlvatlon 1s thought to mhlblt at that level the NE release thus modulatmg RSNA ',*s3 The physlologcal role of presynaptlc DA, receptors on the regulation of renal hemodynamlcs and so&urn reabsorption has been questioned since neither actmanon by endogenous DA of these receptors nor potentlatlon by DA1 blockade of the effects of renal nerve stlmulatlon m animals have been demonstrated ' 4,5 Nonetheless, pharmacologcal DA, blockade has been shown to blunt markedly the renal responses to a number of different renal vasodllatmg and natnuretlc manoeuvers, including low-dose DA mfuslon," extracellular fluid volume expansion with salme solutlon,7 central blood volume expansion with lower body negative pressure8 or head-out water lmmerslon,B and ammo acid infusion lo These effects have been obtained with DA, mhlbltmg drugs at doses that exert usually almost no effect on baseline renal hemodynamlcs and sodmm excretion It IS worth noting that under condltlons known to be sensmve to DA2 blockade, such as ammo acid load and salme mfuslon,7,10-12 renal vasodllatlon and natnuresls have been shown to be at least m part dependent on the integrity of L-Argmme-NO pathway In addition, possible mteractlons between SNS and NO have been investigated to explain renal vasoconstnctlon and sodium retention followmg mhlbltlon of basal NO synthesis with L-Argmme analogues, such as L-NMMA, L-NAME and L-NNA 13-18 Until now, no studies have been made m humans on the relatlonshlp between tome NO-dependent regulation of renal function and DA or SNS Thus, we have conducted the present study m healthy humans to mvestlgate the effects of m the study, after the study protocol had been approved by the Etlucal Committee of our mstltution, and written Informed consent had been obtained by each subject The followmg mclusion criteria were used All the subjects were aged less than 40 years, had no evidence or history of disease of heart, liver, kidneys, or endocrine organs, had not abused alcohol or drugs, and were not currently under medical treatment Pnor to the study, all subjects had a chmcal exammatlon, blood pressure measurement, electrocardlogram and laboratory screening Chmcal data and laboratory results are given m Table 1 Experimental Procedure Each subject was submitted m randomized order to three infusion stuches, the first with L-SULP alone, the second with L-NAME alone, the third with both drugs In women, experiments were performed around the nudpomt of the menstrual cycle Before each expemnent, subjects were maintained for 5 days on a controlled diet provldmg 240mM Na, 80mM K, and 1800 to 2400 kcal per day At 10 00 I'M ampoules, Ravlzza) was used, whereas pharmaceutlcal-grade L-NAME was obtained from Chnalfa
Analytical Methods
Na was measured by flame photometry, L,l by atomic absorption spectrophotometry, and plasma and mfusate PAH and muhn as previously described" PRL was measured by rachcnmmunoassay" and NO, after NADPH oxldatlon also as previously described I9 No adverse effect due to L-SULP or L-NAME admmlstratlon was observed Table 2 summarizes the results of our experiments for MAP and renal hemodynamlcs While L-SULP alone did not exert any effect, L-NAME alone was followed by a slight, but slgmficant rise m MAP only after 45 minutes of infusion Renal hemodynamlcs was widely altered by L-NAME even at 0 to 45 minutes (Pl), when MAP was unchanged
In that penod, GFR dlmmlshed by about 8%, ERPF declined by 10 2%, and RVR increased by 13% All these changes were more pronounced m the 45-to-90 minute infusion period, (PJ, when RVR was 25 6% higher than that calculated at baseline With L-NAME plus L-SULP, changes m MAP were the same, while those m ERPF, RBF, and RVR were all significantly greater than with L-NAME alone m both P, and P2 In P2 RVR was 59 1% higher than at baseline Conversely, the fall m GFR was not different between L-NAME alone and L-NAME plus L-SULP By consequence, FF, which showed only a modest increase m PZ with L-NAME (+4%), was markedly augmented even m P, durmg L-NAME plus L-SULP mfuslon with a further significant rise during P2 (+29 3% versus baselme)
In Table 3 , we summarize the effects of the different infusion experiments on plasma PRL, renal handling of LI and Na, and excretion rate of NO, (UNO,V).
L-SULP alone produced, as expected, a marked nse m plasma PRL, thus showing an effective blockade of DA2 receptors, without any significant variation m Ll, Na and NO, excretion Infusion of L-NAME alone did not affect PRL, while it ehclted a progressive decline m both absolute and fractlonal excretion of Ll and Na with values of UNaV, FENa, CL1, and FELI slgmficantly lower m PZ than m P, These changes m Na and Ll handling were markedly greater with the combined infusion of L-NAME and L-SULP, which produced the same nse m PRL as that with L-SULP alone and decrements m UNO,V comparable to those observed with L-NAME alone
Discussion
The aim of the present human study was to investigate whether renal changes following acute L-NAME-induced mhlbltlon ofbasal NO productlon are potentlated by blockade of DA system with L-SULP Plasma PRL, used as an indirect marker of DA blockade, mcreased substantially, as expected, with infusion of L-SULP alone L-NAME alone did not alter basal PRL, as previously observed m rats.2'1 With L-SULP plus L-NAME mfuslon, changes m PRL were essentially the same as those observed with L-SULP alone Although complex mteractlons between NO and local systems controlling PRL release m hypothalamus have been recently dlscovered, *' this latter finding indicates that the potent stimulus produced by DA,-blockade on PRL release overwhelmed any other interference potentially dependent on NO blockade Infusion of L-SULP alone did not affect baselme renal hemodynamlcs and cation handling This 1s m agreement with that observed m most, although not m all, human studies on the effect of DA, blockade by itself on renal function Bughl et a122 showed that DA1 blockade with domperldone can reduce ERPF m normal humans maintained at a low or intermediate Na intake, but 1s not effective at a 220 mmol Na intake, which 1s very close to that adopted m the present study Low-dose L-NAME mfuslon alone resulted m significant changes m basal renal hemodynamlcs and tubular reabsorption These include substantial renal vasoconstnctlon, slight reduction m GFR and elevation m FF, relatively independent of changes m MAP, which rose significantly (+6%) only after 45 minutes of L-NAME infusion In addition, both absolute and fractlonal excretion of LI and Na fell progressively These variations are consistent with previous animala and human24 mvestlgatlons, including our own recent study'" performed with the same L-NAME infusion technique as that presented here Dunng comfuslon of L-NAME and L-SULP, UNO,V fell at the same extent as during L-NAME alone This indicates b = baseline, PI = 0 to 45 mm of infusion, P2 = 45 to 90 mm of InfusIon, Mean -+ SEM *P< 001 vs b, t f< 001 vs L-SULP,S P-z 05 vs P,, 9 P< 01 vs P,, 1 P< 05 vs L-NAME that the different magnitude of renal changes between the two mfuslons was not due to vanatlons m the degree of NO synthesis mhlbltlon, at least mto the limits of UNO,V as an approximate marker of whole body and, presumably, renal metabolism of NO, As the mam finding from the present study, changes m renal hemodynamlcs and cation handling due to L-NAME were markedly potentlated by the smn&aneous infusion of L-SULP, which produced a two-times amphficatlon of the fall m ERPF and RBF and the nse m RVR subsequent to L-NAME alone Since the drop m GFR was roughly the same with or without comfused L-SULP, the small (+4%) but significant nse m FF with L-NAME alone was enormously potentlated (+29%) Such a change m FF may explain, at least m part, the accentuated increase m fractional reabsorption of both Na and Ll followmg L-NAME plus L-SULP mfuslon Actually, a great increase m FF with consequent elevation m pentubular oncotlc pressure and a fall m pentubular hydrostatic pressure owing to glomerular vasoconstnctlon may act as hemodynamlcally mechated physlcal forces to further increase reabsorption Soares da Sllva et alz5 reported an increased urinary DA excretion m long-term, L-NAME-treated rats Conversely, Haynes et al 2h observed a reduction m urinary DA In humans acutely infused with L-NMMA This latter finding, obtalried under experimental conditions close to those adopted by ps, may suggest that a reduced renal DA production may particlpate m Na retention following NO mhlbltlon
We did dot measure unnary DA Whatever the change, if any, elicited by our expenmental procedure on renal DA production, any significant relatlonshlp between potentlatmg effects of L-SULP and unnary DA excretion IS very unhkely Indeed, urinary DA reflects almost exclusively the DA production by tubular cells Tubular DA does not elicits any demonstrated modulation on renal hemodynanucs and exerts its natrmretlc effect at the tubular level as an autocnne-paracrme substance through an actlvatlon of DA, receptors,1,3-5 while blockade of DA system with L-SULP takes place mainly at the level of presynaptlc DA1 receptors SULP 1s known to be a highly specific mhlbltor of DA receptors 1-3 Moreover, studies on SULP enantlomers have indicated that L-SULP 1s much more potent of D-SULP on DA, receptors m various vascular tissues *J,*~-*~ In addition, L-SULP showed marked stereoselectlve antagonisms upon preJunctlona1 DA, receptors m different vascular tlssues,2,27-2y including those of the kidney *' Finally, recent work by Rump et a13" has demonstrated that both L-SULP and dompendone, but not DA, blockers, do prevent m human ludney tissue the mlnbltlon of electrically induced NE release produced by actlvatlon of DA2 receptors with specific presynaptlc DA, agonists This confirms not only the existence of renal prejunctlonal DA, receptors m man, but also their functional properties of modulation of neuronal NE release Thus it seems to reasonable to assume that L-SULP affects L-NAME-induced changes m renal function mainly through the mhltntlon of preJunctlona1 DA2 receptors m the kidney, with subsequent absolute or relative increase m NE release at the presynaptlc level and enhancement of RSNA However, the physlologcal role of preJunctlona1 DA2 receptors m controlling renal function is still uncertain 1,3-5
Based on several animal studies m which DA, blockade failed to enhance the effects of electrical stimulation of renal nerves,4 the conclusion has been reached that there 1s no physlologcal role for DA, receptors and, more generally, for DA containing nerves m regulatmg renal hemodynamlc and tubular function 4.5 Even m recent studies by Rump et al,3" L-SULP and dompendone did not prevent the Increase m NE release due to electrical stlmulatlon of human kidney tissue unless DA, receptors were activated by specific agomstlc drugs Agnoh et al6 observed that L-SULP, which 1s usually devoid of renal effects under basal conditions as shown m the present study, IS much more effective than D-SULP m mhlbltmg renal vasodllatlon and natrmresls induced by low-dose DA infusion m humans This may suggest that actlvatlon of DA, receptors (m this case by the physlologcal, but exogenous substrate DA) 1s necessary to unmask then vasodllatory and natnuretlc properties, whereas a direct demonstration of a physlologcal activation of presynaptlc DA2 receptors by endogenous DA 1s not yet available 4 5 3"
Montanari et al
On the other hand, when pharmacologcal DA2 blockade has been performed m humans under experimental condltrons associated with reduced rather than increased RSNA, such as central blood volume expansion by lower body negative pressure8 or head-out water lmmerslon," the consequent natrmretlc and ren,ll vasodllatmg responses have been found to be slgmficantly Inhibited Thus, presynaptlc DA, receptors seem to play an important physlologlcal role at least under these particular condltlons, where their blockade could be effective by preventing the appropriate reflex decrease m RSNA, followmg activation of mechanoreceptors due, m turn, to the centrahzatlon of blood volume It 1s of interest that a presumed reflex decrease m SNS actlvlty has also been demonstrated m humans submitted to NO-mhlbltlon with acute L-NMMA mfuslon with subsequent rise m MAP ?' Thus the hypothesis may be advanced, although not demonstrated, that a NO mhlbltlon-induced reduction m SNS activity, slmllar to that operating m central blood volume expansion, allows DA2 receptor blockade to exert its effects on renal function
The relationship between SNS (or RSNA) activity and renal effects of NO synthesis mhlbltlon has been widely mvestlgated Studies m rats have indicated that renal denervatlon or chemical sympathectomy delay the onset or reduce the seventy of L-NAME-induced hypertension I3 Moreover, when RSNA m rats 1s increased with carotid artery occlusion systemic and renal effects of L-NAME are markedly potentlated I4 Studies m conscious dogsI and chronically instrumented, conscious ratsI with renal denervatlon have shown, however, that basal RSNA 1s not involved m renal vasoconstnctlon Induced by L-NAME On the other hand, mvestlgatlons of dogs17 and ratsI infused mtrarenally with NE have demonstrated that NO mhlbmon markedly exaggerates renal responses to acute NE and that these changes are not sustamed chronically unless renal NO production 1s mhlblted This led the authors17*18 to suggest that basal renal NO production substantially modulates renal actions of NE Taken together, all these findings Indicate that basal, not stimulated SNS actlvlty by Itself, has little effect on renal changes to NO mhlbltlon, while marked potentlatlon follows stlmulatlon of SNS secondary to carotid occluslon2" or even to stress due to surgical preparation or anesthesia I6 In addition, since renal hemodynanuc effects of mtrarenal NE are markedly accentuated by NO mhlbltlon, basal NO production may serve as a physlologlcal antagonist of increased RSNA l7 lx A combmatlon of an increased RSNA (or elevated renal content of NE) and an inhibited NO production, such as that obtained m the above mentioned experimental studles,14s17 lx may resemble the condltlons of the present human study In fact, when renal NO production 1s inhibited by L-NAME and DA, receptors are simultaneously blocked by L-SULP with subsequent Increase (or, perhaps, lmpalred decrease) m RSNA, renal vasoconstnctlon ,md Na retention take place at an extent much greater than with L-NAME alone On the other hand, DA2 blockade by itself has no effect on basal renal function, and it produces renal vasoconstnctlon and antmatnuresls only under NO mhlbmon If we assume that preJunctlona1 DA2 blockade per se may stimulate RSNA, we might suggest that NO may act as a physlologlcal buffering mechanism for increase m RSNA, thus confirmmg the findmgs obtained m animal studies '7 lx Of course, a maJor hmltatlon of this interpretation rests as previously pointed out, on the uncertainty of the physlologcal actlvatlon by endogenous DA of preJunctlona1 DA2 receptors and, by consequence, of the effect of then blockade under both baseline condmons and NO mhlbltlon
In conclusion, we demonstrate m the present study that simultaneous blockade of both DA system at the level of preJunctlona1 DA2 receptors and NO synthesis produces m the human kidney profound changes m hemodynamlc and tubular functions, with intense vasoconstnctlon and marked sodium retention Since these changes are much greater that those observed with NO mhlbltlon alone, while DA2 blockade by Itself has no effect, we suggest that mteractlons between presynaptlc DA, receptors and NO system play a physlologlcal role m the regulation of renal hemodynamlcs and tubular function
Further mvestlgatlon 1s required m order to clarify whether this interaction 1s mediated by the interplay between NO production and modulation of SNS activity m the kidney operated by the neural presynaptlc DA2 receptors 
